With a population of only 350,000, Ticino has a remarkably well developed pharmaceutical cluster. FIT Chairman Giorgio Calderari explains that the cluster’s key strength lies in the diverse range of capabilities which its members are able to offer as contract services to one another, and of course other interested third parties.
What are the key points in the story of how a pharma cluster was born in Ticino?
"The great strength of this small territory is that if you view the pharma industry as a sort of “virtual company”, you will essentially see a CHF 2 billion (USD 2 billion) entity with over 2000 employees, and a huge range of capabilities and specializations."
